CLINICAL_TRIALS
trial_result
· 2016-03-22
Clinical Trial Update: Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer [Phase 2]
Summary
A Phase 2 neoadjuvant trial in breast cancer evaluating chemotherapy plus lapatinib and trastuzumab has completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2016-03-22